Reasons Bryan M.
Insider CIK 1553489 · IPXL Chief Financial Officer · ACRS Director · MNK EVP & CFO · REPH Director · AMRX CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NONE Mallinckrodt plc | A Award deriv | 2025-07-31 | 2025-08-04 | 41,035 | — | $0 | 54,714 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise deriv | 2025-01-01 | 2025-01-02 | 6,838 | — | $0 | 13,679 | SEC↗ |
| NONE Mallinckrodt plc | F Tax w/h | 2025-01-01 | 2025-01-02 | 1,724 | — | $0 | 5,114 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise | 2025-01-01 | 2025-01-02 | 6,838 | — | $0 | 6,838 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 28,732 | SEC↗ |
| SCTL Societal CDMO, Inc. | D To issuer deriv | 2024-04-08 | 2024-04-08 | 118,182 | — | $0 | 0 | SEC↗ |
| SCTL Societal CDMO, Inc. | D To issuer deriv | 2024-04-08 | 2024-04-08 | 27,229 | — | $0 | 0 | SEC↗ |
| SCTL Societal CDMO, Inc. | D To issuer | 2024-04-08 | 2024-04-08 | 73,620 | $1.10 | $81.0K | 0 | SEC↗ |
| SCTL Societal CDMO, Inc. | U Tender | 2024-04-08 | 2024-04-08 | 217,429 | $1.10 | $239.2K | 73,620 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2024-02-02 | 2024-02-06 | 20,517 | — | $0 | 20,517 | SEC↗ |
| MNKTQ Mallinckrodt plc | D To issuer | 2023-11-14 | 2023-11-16 | 96,660 | — | $0 | 0 | SEC↗ |
| SCTL Societal CDMO, Inc. | P Buy | 2023-08-28 | 2023-08-28 | 62,500 | $0.40 | $25.0K | 291,049 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2023-08-17 | 2023-08-18 | 15,976 | $0.69 | $11.0K | 96,660 | SEC↗ |
| MNK Mallinckrodt plc | D To issuer deriv | 2023-06-30 | 2023-07-05 | 168,237 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 24,072 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 4,660 | — | $0 | 4,660 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 15,750 | — | $0 | 15,750 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 27,229 | — | $0 | 27,229 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2023-05-17 | 2023-05-19 | 73,620 | — | $0 | 228,549 | SEC↗ |
| MNK Mallinckrodt plc | A Award deriv | 2023-04-03 | 2023-04-05 | 168,237 | — | $0 | 168,237 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2022-12-14 | 2022-12-22 | 112,636 | — | $0 | 112,636 | SEC↗ |
| MNKPF Mallinckrodt plc | D To issuer deriv | 2022-06-16 | 2022-06-21 | 57,569 | — | $0 | 0 | SEC↗ |
| MNKPF Mallinckrodt plc | D To issuer | 2022-06-16 | 2022-06-21 | 11,593 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 19,565 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 4,507 | — | $0 | 4,507 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award deriv | 2022-05-18 | 2022-05-20 | 118,182 | — | $0 | 118,182 | SEC↗ |
| SCTL Societal CDMO, Inc. | A Award | 2022-05-18 | 2022-05-20 | 87,500 | — | $0 | 154,929 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 3,356 | — | $0 | 3,356 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 12,250 | — | $0 | 12,250 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2021-04-20 | 2021-04-22 | 38,012 | — | $0 | 38,012 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2021-04-20 | 2021-05-17 | 38,012 | — | $0 | 38,012 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2021-04-20 | 2021-04-22 | 26,923 | — | $0 | 67,429 | SEC↗ |
| MNKKQ Mallinckrodt plc | S Sale | 2020-12-03 | 2020-12-07 | 5,400 | $0.17 | $918 | 11,593 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-06-06 | 2020-06-08 | 7,333 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-06-06 | 2020-06-08 | 7,333 | — | $0 | 16,209 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 16,500 | — | $0 | 16,500 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2020-05-07 | 2020-05-11 | 12,405 | — | $0 | 12,405 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2020-05-07 | 2020-05-11 | 8,363 | — | $0 | 40,506 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2020-04-01 | 2020-04-03 | 986 | $1.93 | $1.9K | 16,993 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 8,876 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 8,876 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-12-05 | 2019-12-09 | 9,156 | — | $0 | 32,143 | SEC↗ |
| MNK Mallinckrodt plc | P Buy | 2019-06-07 | 2019-06-07 | 5,400 | $8.96 | $48.4K | 17,979 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 7,333 | — | $0 | 7,333 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 10,888 | — | $0 | 10,888 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-05-09 | 2019-05-10 | 7,955 | — | $0 | 22,987 | SEC↗ |
| MNK Mallinckrodt plc | A Award deriv | 2019-04-01 | 2019-04-03 | 57,569 | — | $0 | 57,569 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2019-04-01 | 2019-04-03 | 12,579 | — | $0 | 12,579 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2018-08-21 | 2018-08-23 | 11,698 | $23.65 | $276.7K | 82,986 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2018-05-12 | 2018-05-14 | 8,849 | — | $0 | 0 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2018-05-12 | 2018-05-14 | 8,849 | — | $0 | 15,032 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-08 | 33,311 | — | $0 | 33,311 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-08 | 136,240 | — | $0 | 136,240 | SEC↗ |
| IPXL Impax Laboratories, LLC | D To issuer deriv | 2018-05-04 | 2018-05-08 | 52,000 | — | $0 | 0 | SEC↗ |
| IPXL Impax Laboratories, LLC | D To issuer deriv | 2018-05-04 | 2018-05-08 | 55,000 | — | $0 | 0 | SEC↗ |
| IPXL Impax Laboratories, LLC | D To issuer deriv | 2018-05-04 | 2018-05-08 | 47,500 | — | $0 | 0 | SEC↗ |
| IPXL Impax Laboratories, LLC | D To issuer deriv | 2018-05-04 | 2018-05-08 | 63,095 | — | $0 | 0 | SEC↗ |
| IPXL Impax Laboratories, LLC | D To issuer deriv | 2018-05-04 | 2018-05-08 | 56,232 | — | $0 | 0 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2018-05-04 | 2018-05-08 | 5,742 | — | $0 | 5,742 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-04 | 2018-05-08 | 56,232 | — | $0 | 56,232 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-04 | 2018-05-08 | 63,095 | — | $0 | 63,095 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-04 | 2018-05-08 | 47,500 | — | $0 | 47,500 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-04 | 2018-05-08 | 55,000 | — | $0 | 55,000 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-04 | 2018-05-08 | 52,000 | — | $0 | 52,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2018-05-04 | 2018-05-10 | 8,965 | — | $0 | 8,965 | SEC↗ |
| IPXL Impax Laboratories, LLC | D To issuer | 2018-05-04 | 2018-05-08 | 53,423 | — | $0 | 0 | SEC↗ |
| IPXL Impax Laboratories, LLC | D To issuer | 2018-05-04 | 2018-05-08 | 20,566 | — | $0 | 0 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2018-05-04 | 2018-05-08 | 6,183 | — | $0 | 6,183 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award | 2018-05-04 | 2018-05-08 | 94,684 | — | $0 | 94,684 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-04-20 | 2018-04-23 | 16,000 | — | $0 | 16,000 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2018-03-02 | 2018-03-05 | 3,069 | $19.50 | $59.8K | 94,684 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2018-02-26 | 2018-02-27 | 6,141 | $20.95 | $128.7K | 97,753 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2017-05-15 | 2017-05-16 | 454 | $16.80 | $7.6K | 103,894 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2017-05-14 | 2017-05-16 | 705 | $17.65 | $12.4K | 104,348 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-05-12 | 2017-05-16 | 8,849 | — | $0 | 8,849 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-03-03 | 2017-03-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award deriv | 2017-03-02 | 2017-03-06 | 56,232 | — | $0 | 56,232 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2017-03-02 | 2017-03-06 | 23,272 | — | $0 | 105,053 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2017-02-26 | 2017-02-27 | 5,715 | $14.05 | $80.3K | 81,781 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2016-10-26 | 2016-10-27 | 1,209 | $21.35 | $25.8K | 87,496 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2016-05-15 | 2016-05-16 | 1,216 | $29.18 | $35.5K | 88,705 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2016-05-14 | 2016-05-16 | 1,889 | $29.18 | $55.1K | 89,921 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2016-04-13 | 2016-04-14 | 1,035 | $35.35 | $36.6K | 91,810 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award deriv | 2016-02-26 | 2016-03-01 | 63,095 | — | $0 | 63,095 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2016-02-26 | 2016-03-01 | 1,958 | $33.27 | $65.1K | 66,732 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2016-02-26 | 2016-03-01 | 26,113 | — | $0 | 92,845 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2015-10-26 | 2015-10-27 | 1,299 | $35.97 | $46.7K | 68,690 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2015-05-15 | 2015-05-19 | 1,391 | $44.44 | $61.8K | 69,989 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2015-05-14 | 2015-05-19 | 2,161 | $44.82 | $96.9K | 71,380 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2015-04-13 | 2015-04-15 | 1,205 | $50.90 | $61.3K | 73,541 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award deriv | 2015-02-26 | 2015-03-12 | 47,500 | — | $0 | 47,500 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2015-02-26 | 2015-03-12 | 20,000 | — | $0 | 74,746 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2014-10-26 | 2014-10-28 | 940 | $27.80 | $26.1K | 54,746 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2014-05-15 | 2014-05-16 | 1,400 | $25.56 | $35.8K | 55,686 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award deriv | 2014-05-14 | 2014-05-16 | 55,000 | — | $0 | 55,000 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2014-05-14 | 2014-05-16 | 23,000 | — | $0 | 57,086 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2014-04-13 | 2014-04-14 | 1,216 | $24.55 | $29.9K | 34,086 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2013-10-26 | 2013-10-28 | 939 | $20.47 | $19.2K | 35,302 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award deriv | 2013-05-15 | 2013-05-16 | 52,000 | — | $0 | 52,000 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2013-05-15 | 2013-05-16 | 14,800 | — | $0 | 36,241 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2013-04-13 | 2013-04-16 | 1,159 | $16.46 | $19.1K | 21,441 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2012-10-26 | 2013-02-15 | 10,000 | — | $0 | 22,600 | SEC↗ |